Veterinary in vitro fertilization (IVF) market was valued at USD 3.80 billion in 2021

LEICESTER, U.K. - Oct. 12, 2022 - PRLog -- The global veterinary in vitro fertilization (IVF) market was valued at USD 3.80 billion in 2021 and it is predicted to rise at a compound annual growth rate (CAGR) of 6.50 % from 2022 to 2032. The term "in vitro fertilization" (IVF) is used clinically for both cattle and people. Oocytes can be collected from cows in vivo up to twice a week using a transvaginal ultrasound-guided follicular puncture technique under this in cattle. The main reason for driving the growth of the veterinary in vitro fertilization (IVF) industry is the increase in endangered animals and the rising need for better progeny. The veterinary in vitro fertilization (IVF) market is also expected to rise as a result of technological innovation and advancement in effective techniques. The veterinary in vitro fertilization (IVF) business is restricted by high production costs and a shortage of qualified experts while growing public awareness of ethical questions involving animals will restrict market expansion.

"Rise in Technological Innovation of in Vitro Fertilization (IVF) Fuels the Market"

Various factors such as the risks involved with animal breeding and disease transmission are the major factors leading to market growth. The market for veterinary in vitro fertilization is rising as a result of increasing productivity using AI technologies. Female IVF new-born is found to have higher milk production than normal infants. Additionally, useful in avoiding the spread of bacterial diseases is the use of IVF techniques that contain antibiotics.

Quick Buy–Global Veterinary in Vitro Fertilization (IVF) Market:
https://quintileinsights.com/checkout/120305

BY REGIONAL OUTLOOK:

On the basis of geography, the veterinary in vitro fertilization (IVF) market is segmented into

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Recent Developments:

• For instance, Genus plc and Beijing Capital Agribusiness (BCA), a Chinese company, partnered in May 2019. BCA is anticipated to provide the business with proprietary technological applications to create animals' immune to the Porcine Reproductive and Respiratory Syndrome Virus (PrRVS).

To learn more about this report, please copy this link and paste it into the search bar to get the best deal: https://quintileinsights.com/enquiry/inquire-before-buy/120305-veterinary-in-vitro-fertilization-ivf-market

The following are some of the major market players operating across the globe:

• Bovine Elite LLC
• KRUUSE
• Agtech Inc.
• IMV Technologies
• Zoetis Inc.
• Neogen Corporation
• National Meditec
• Swine Genetics International
• Select Sires Inc.

Contact
Quintile Insights
Name: Samidha J
Email: sales@quintileinsights.com